MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1084/jem.20211862

Медицинская библиотека · The Journal of experimental medicine · 2021

Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge.

Hilligan Kerry L, Namasivayam Sivaranjani, Clancy Chad S, O'Mard Danielle, Oland Sandra D, Robertson Shelly J, Baker Paul J, Castro Ehydel, Garza Nicole L, Lafont Bernard A P, Johnson Reed, Ronchese Franca, Mayer-Barber Katrin D, Best Sonja M, Sher Alan

СтатьяПоддержка NIH: внешняя программаResearch Support, N.I.H., IntramuralПеревод в очереди

Аннотация

In addition to providing partial protection against pediatric tuberculosis, vaccination with bacille Calmette-Guérin (BCG) has been reported to confer nonspecific resistance to unrelated pulmonary pathogens, a phenomenon attributed to the induction of long-lasting alterations within the myeloid cell compartment. Here, we demonstrate that intravenous, but not subcutaneous, inoculation of BCG protects human-ACE2 transgenic mice against lethal challenge with SARS-CoV-2 (SCV2) and results in reduced viral loads in non-transgenic animals infected with an α variant. The observed increase in host resistance was associated with reductions in SCV2-induced tissue pathology, inflammatory cell recruitment, and cytokine production that multivariate analysis revealed as only partially related to diminished viral load. We propose that this protection stems from BCG-induced alterations in the composition and function of the pulmonary cellular compartment that impact the innate response to the virus and ensuing immunopathology. While intravenous BCG vaccination is not a clinically acceptable practice, our findings provide an experimental model for identifying mechanisms by which nonspecific stimulation of the pulmonary immune response promotes host resistance to SCV2 lethality.

Для цитирования: Hilligan Kerry L, Namasivayam Sivaranjani, Clancy Chad S, O'Mard Danielle, Oland Sandra D, Robertson Shelly J, Baker Paul J, Castro Ehydel, Garza Nicole L, Lafont Bernard A P, Johnson Reed, Ronchese Franca, Mayer-Barber Katrin D, Best Sonja M, Sher Alan. Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge.. The Journal of experimental medicine. 2021. DOI: 10.1084/jem.20211862.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.